Loading clinical trials...
Loading clinical trials...
A Randomized, Double-Blind, 6-Way Crossover Study to Determine the Abuse Potential of Tozadenant Relative to D-Amphetamine and Placebo When Administered Orally in Healthy, Non-Dependent, Recreational Polydrug Users With Stimulant Experience, Under Fed Conditions
Conditions
Interventions
Tozadenant
Placebo oral tablet
+2 more
Locations
1
Canada
INC Research Toronto, Inc.
Toronto, Ontario, Canada
Start Date
September 18, 2017
Primary Completion Date
November 28, 2017
Completion Date
November 28, 2017
Last Updated
August 13, 2018
NCT05106153
NCT04570436
NCT01987739
Lead Sponsor
Biotie Therapies Inc.
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions